These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo. Zhang Y; Liu F; Zheng J; Jiang K; Ai H; Liu L; Mao D Exp Cell Res; 2024 Feb; 435(1):113913. PubMed ID: 38199479 [TBL] [Abstract][Full Text] [Related]
3. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer. Lin YW; Ren LL; Xiong H; Du W; Yu YN; Sun TT; Weng YR; Wang ZH; Wang JL; Wang YC; Cui Y; Sun DF; Han ZG; Shen N; Zou W; Xu J; Chen HY; Cao W; Hong J; Fang JY J Pathol; 2013 Jul; 230(3):277-90. PubMed ID: 23424038 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions. Zeng X; Chen S; Huang H Cell Cycle; 2011 Feb; 10(4):579-83. PubMed ID: 21278485 [TBL] [Abstract][Full Text] [Related]
5. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation. Bamidele AO; Svingen PA; Sagstetter MR; Sarmento OF; Gonzalez M; Braga Neto MB; Kugathasan S; Lomberk G; Urrutia RA; Faubion WA Cell Mol Gastroenterol Hepatol; 2019; 7(1):55-71. PubMed ID: 30510991 [TBL] [Abstract][Full Text] [Related]
6. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells. Li H; Cai Q; Godwin AK; Zhang R Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743 [TBL] [Abstract][Full Text] [Related]
7. ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer. Tang B; Sun R; Wang D; Sheng H; Wei T; Wang L; Zhang J; Ho TH; Yang L; Wei Q; Huang H Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593912 [TBL] [Abstract][Full Text] [Related]
8. JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic. Chen B; Liu J; Chang Q; Beezhold K; Lu Y; Chen F Cell Cycle; 2013 Jan; 12(1):112-21. PubMed ID: 23255093 [TBL] [Abstract][Full Text] [Related]
9. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer. Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. Wan L; Xu K; Wei Y; Zhang J; Han T; Fry C; Zhang Z; Wang YV; Huang L; Yuan M; Xia W; Chang WC; Huang WC; Liu CL; Chang YC; Liu J; Wu Y; Jin VX; Dai X; Guo J; Liu J; Jiang S; Li J; Asara JM; Brown M; Hung MC; Wei W Mol Cell; 2018 Jan; 69(2):279-291.e5. PubMed ID: 29351847 [TBL] [Abstract][Full Text] [Related]
11. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2. Chen XJ; An N J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896 [TBL] [Abstract][Full Text] [Related]
13. EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer. Chen J; Hong JH; Huang Y; Liu S; Yin J; Deng P; Sun Y; Yu Z; Zeng X; Xiao R; Chan JY; Guan P; Wang Y; Wang P; Liu L; Wen S; Yu Q; Ong CK; Teh BT; Xiong Y; Tan J Mol Cancer; 2023 May; 22(1):85. PubMed ID: 37210576 [TBL] [Abstract][Full Text] [Related]
14. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis. Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422 [TBL] [Abstract][Full Text] [Related]
15. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells. Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152 [TBL] [Abstract][Full Text] [Related]
17. STAT3-driven transcription depends upon the dimethylation of K49 by EZH2. Dasgupta M; Dermawan JK; Willard B; Stark GR Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3985-90. PubMed ID: 25767098 [TBL] [Abstract][Full Text] [Related]
18. The histone H3K27 methylation mark regulates intestinal epithelial cell density-dependent proliferation and the inflammatory response. Turgeon N; Blais M; Delabre JF; Asselin C J Cell Biochem; 2013 May; 114(5):1203-15. PubMed ID: 23192652 [TBL] [Abstract][Full Text] [Related]
19. Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification. Gherardi S; Ripoche D; Mikaelian I; Chanal M; Teinturier R; Goehrig D; Cordier-Bussat M; Zhang CX; Hennino A; Bertolino P Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):427-437. PubMed ID: 28215965 [TBL] [Abstract][Full Text] [Related]